Strengthening Transfusion Safety with Innovative Solutions
On World AIDS Day, Tianlong takes a significant step forward in the realm of health by unveiling its cutting-edge nucleic acid blood screening solution. This breakthrough technology is designed to improve transfusion safety on a global scale, combining automated processes with high-sensitivity NAT reagents to detect infections earlier than ever before.
The Importance of Early Detection
Blood safety is paramount in medical practices worldwide, and early detection plays a critical role in safeguarding against transfusion-transmitted infections. By enhancing the accuracy of blood screening, Tianlong's solutions ensure that laboratories can swiftly identify and address potential infections, including HBV, HCV, HIV-1, and HIV-2. This dedication to rigorous testing reinforces public trust and underlines the safety of every blood donation.
Innovative Automated Workflow for Blood Screening
At the core of Tianlong’s offering is the Aurora PANA X6 Fully Automated Nucleic Acid Extraction System, specifically engineered for blood centers and extensive screening programs. Coupled with the Gentier 96 Real-time PCR System, this platform facilitates a true sample-in, result-out experience, streamlining processes such as tube loading, barcode identification, sample pooling, nucleic acid extraction, and PCR amplification. The automatic workflow not only reduces manual steps but also mitigates risks associated with contamination, thereby enhancing operational safety.
Efficiency for High-Volume Testing
The Aurora PANA X6 is capable of processing an impressive up to 576 samples in a single run and a staggering 1,152 samples daily. This capacity ensures that laboratories can meet the demanding nature of high-volume blood screening, while features like automated capping/decapping of sample tubes guarantee a consistent and contamination-free operation.
Advanced Testing Options and Biosafety Measures
Designed for optimal performance, the system includes direct pooling into deep-well plates, which eliminates the use of extra collection tubes, along with options for individual testing and pooled testing strategies. Safety and reliability are further enhanced through independent work zones, HEPA filtration, and UV disinfection, ensuring robust performance even under demanding laboratory conditions.
High-Sensitivity NAT Reagents
Tianlong’s advanced high-sensitivity NAT reagents play a crucial role in identifying low-load infections. These reagents utilize qualitative real-time PCR in a compact all-in-one format that seamlessly integrates extraction and amplification, enhancing the overall efficiency of the blood screening process.
Shared Commitment on World AIDS Day
On this important day, the emphasis on early-window detection serves as a powerful reminder of our united effort to protect every individual connected to blood donation and transfusion activities. Tianlong's strategic advancements demonstrate the company's unwavering commitment to improving public health.
Voicing the Commitment to Safety
Li Ming, the CEO of Tianlong, shared insightful thoughts regarding their mission, stating, "Every safe transfusion represents a promise of protection for another human life. We are dedicated to providing laboratories with the tools needed to enhance testing accuracy, fortify biosafety, and contribute to the global initiative aimed at preventing HIV transmission."
About Tianlong Science and Technology
Tianlong Science and Technology, established in 1997, is a recognized pioneer in genetic testing and molecular diagnostics. Collaborating with Shanghai Kehua Bio-engineering Co., Ltd. (KHB), the company operates across five primary technology platforms focusing on immunodiagnostics, biochemistry, molecular diagnostics, POCT, and mass spectrometry. These platforms cater to various sectors, including clinical diagnostics, blood centers, disease control, veterinary epidemic prevention, and food safety.
Frequently Asked Questions
What is Tianlong's main focus regarding blood screening?
Tianlong focuses on enhancing the safety and efficiency of blood screening through innovative nucleic acid testing solutions aimed at early detection of infections.
What technology does Tianlong use for blood screening?
Tianlong utilizes the Aurora PANA X6 Fully Automated Nucleic Acid Extraction System, paired with the Gentier 96 Real-time PCR System to streamline blood testing processes.
How does the Aurora PANA X6 enhance blood safety?
This system automates critical processes in blood screening, which reduces manual handling and lowers the risk of contamination, ultimately ensuring safer transfusions.
What is the capacity of the Aurora PANA X6?
The system can process up to 576 samples per run and handle up to 1,152 samples in a single day, making it highly suitable for high-volume testing.
How does Tianlong's reagents contribute to infection detection?
The high-sensitivity NAT reagents are designed to detect low viral loads, allowing early identification of window-period infections to enhance blood supply safety.
